The FDA Addresses Vaping With TV Ads

The Epidemic of childhood nicotine addiction is being fueled by teenage acceptance of e-cigarettes Vape pens

Wednesday, August 14, 2019 - Vape pens may make sense for long-term smokers that are looking to kick the tobacco habit. On its surface, replacing the dirty, disgusting and dangerous habit of smoking tobacco products with a controllable and relatively clean nicotine vapor seems like a good idea. And for many it is. Vaping is designed to help mature, responsible nicotine-addicted adults quit smoking. Just replace your traditional cigarettes with a Vape Pen and a smart app and gradually reduce the nicotine levels you are ingesting. Vaping would be easier than wearing a nicotine patch since it deals only with the levels of nicotine and not the oral fixations of smoking. Instead of merely helping adults quit smoking vaping has caused millions of children and young adults to take up the habit of vaping, and become addicted to nicotine, a dangerous narcotic drug. Statistics indicate that childhood Vape nicotine addiction may lead to smoking actual cigarettes as an adult. No wonder the tobacco companies support vaping, a product that would appear at first glance to compete with cigarettes. JUUL Vape lawsuit attorneys have experienced the aftereffects of numerous major drug and medical device recalls, helping our clients navigate difficult times in life by winning needed compensation.

The epidemic of youth nicotine addiction from vaping has caught the attention of the US Food and Drug Administration that has produced a series of public service announcements designed to warn teenagers of the dangers of vaping. According to Engadget.com, Acting FDA Commissioner Ned Sharpless, MD addressed the issue by stating: "The troubling epidemic of youth vaping threatens to erase the years of progress we've made combatting tobacco use among kids." The FDA's TV ads will target approximately 10 million teenagers who are either addicted to vape nicotine or are at risk of being tempted to try vaping. The ads will try to make teenagers aware that vaping directly leads to cigarette smoking by featuring a magician who turns a vape pen into a cigarette. Close to 4 million teenagers have taken up the vaping habit and experts fear that number could quickly double, and then double again.

Linking vaping to being unhealthy, unfortunately, could be ineffective and could produce the opposite result to the one intended. Teenagers view themselves as indestructible and when an authority figure tells them to do something they have a natural inclination to rebel and do the opposite. The FDA's public awareness announcement may do more harm than good and make vaping seem cool and desirable.

On the legal front, the FDA has accused Juul Labs, the leading, the leading manufacturer and marketers of vape pens market, of targeting children with their Vape pen advertisements and of "undermining the FDA's efforts to prevent teen smoking." The FDA proposes outlawing flavored e-cigarettes that are of particular attraction to kids, according to Engadget. Engadget also reports that San Francisco, home to Juul Labs, is the first city to ban e-cigarettes. NPR.org quoted San Francisco Attorney Dennis Herrera, a co-author of the vape pen ordinance with saying: "This is a decisive step to help prevent another generation of San Francisco children from becoming addicted to nicotine." The city is to be credited with raising awareness of the dangers of youth nicotine addiction from vaping and to more cities following San Francisco's lead in banning the deadly device.

More Recent JUUL Vape Pen Lawsuit News:

Lawyers for JUUL Vape Pen Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.